The approach to evaluation of acid-base disorders used in this on-line text is known as the Boston approach. The researchers promoting this approach are from Boston. An alternative method of evaluation promoted by Astrup and Siggaard-Anderson from Copenhagen uses the Base Excess approach. At times the differences between the two groups has stirred controversy (called the 'Great Trans-Atlantic Acid-Base Debate' by Bunker in 1965). Many of the differences between the two groups persist and it is important to have some understanding of the issues involved. The controversy has recently been stirred again by Severinghaus (1993) who favours the Copenhagen approach.
more fixed acids are present, then a disorder of larger magnitude is present. This is clear enough but in a particular metabolic disorder, we may not know what are the particular fixed acids that are causing the acidosis. Indeed there may be more than one type involved.
Is it feasible to measure every possible fixed acid?
No. BUT we can estimate the total amount of excess fixed acid present indirectly.
The argument goes like this:
1. Buffering of fixed acids in the extracellular fluid is predominantly by bicarbonate.
2. One bicarbonate molecule will react with one H + molecule produced by one molecule of fixed acid.
3. So will decrease by one molecule for every molecule of fixed acid present.
4. The total amount of excess fixed acids should therefore be equal to the amount by which the bicarbonate concentration drops from its usual value.
Conclusion: The magnitude of the metabolic disorder (in the ECF) can be quantified indirectly by the amount of change in the . This seems an improvement because now there is only one quantity to measure and also it is easy to 'measure' (Bicarbonate is not actually measured in a blood-gas machine but instead is calculated, using the Henderson- But there are other problems:
• The implicit assumption so far that pCO 2 and HCO 3 -are independent of one another is not correct (What this means is that changes in pCO 2 also will change the bicarbonate level because these 2 compounds are in chemical equilibrium. This interferes with the usefulness of changes in bicarbonate as a way to quantify the metabolic component of an acid-base disorder because respiratory disorders also alter the baseline HCO 3 -)
• The buffering by the HCO 3 -in the blood sample is not representative of the buffering by the ECF as a whole (What this means is that because blood is a better buffer than ECF as a whole then doing your measurements in a bloodgas machine on blood will not give you results representative of the whole ECF. Blood is a better buffer then the whole ECF because of its content of the buffer haemoglobin.)
• The assumption that all buffering of metabolic acids is by HCO 3 -and not other unmeasured ECF buffers is not totally correct.
• Buffering by intracellular buffers is ignored
• The system assesses compensation as another primary disorder
The Copenhagen approach has developed several 'work-arounds' to cope with some of these problems.
\[ CO_{2} + H_{2}O \Leftrightarrow H_{2}CO_{3} \Leftrightarrow H^{+} + HCO_{3}^{-} \]
This is a problem because a change in respiratory acid is changing the baseline used for assessment of the metabolic disorder. What we need is some way of assessing the metabolic disorder that corrects or allows for this interaction between CO 2 and HCO 3 -.
Several pCO 2 -independent indices have been proposed as being suitable for this purpose:
• Buffer base is a measure of the concentration of all the buffers present in either plasma or blood.
Base Excess (BE) is a measure of how far Buffer Base has changed from its normal value & was introduced by Astrup and Siggaard-Andersen in 1958. BE in whole blood is independent of pCO 2 in the sample when measured in the blood gas machine. BE is proposed as a measure of the magnitude of the metabolic disorder because it assesses all the extracellular buffers (in the blood sample) and is independent of pCO 2 (in vitro). Unfortunately, there are several problems with the use of BE in this way. For example:
• It is not independent of pCO 2 in vivo (This is because blood -which contains haemoglobin -is a better buffer than the total ECF
• It does not distinguish compensation for a respiratory disorder from the presence of a primary metabolic disorder If BE is calculated for a haemoglobin concentration of 30 or 50 g/l instead of the actual haemoglobin, the differences between in vitro and in vivo behaviour can be mostly eliminated (See Severinghaus, 1976 throughout the whole ECF rather than just the intravascular compartment). This attempts to eliminate the error introduced by the incorrect assumption that the buffering of blood is the same as the buffering by the whole ECF.
The Radiometer range of blood gas machines are made in Copenhagen and are very successfully used worldwide.
These machines provides a printout with the full family of 'derived' (or 'contrived', depending on your perspective)
Copenhagen-type blood gas variables for those who are interested. Other brands of machine have usually followed this practice so they can survive in the competitive marketplace. This assists in the survival of the Copenhagen approach.
9.5.2: Background to Boston Approach
The alternative method of quantifying acid-base disorders has been developed by investigators from Boston (eg This approach is based on actual experimental work in humans (eg whole body titrations) rather than on blood samples in a machine.
The aim has been to determine the magnitude of the compensation that occurs to graded degrees of acid-base disturbance.
These results are based on buffering and compensatory processes that affect the whole body rather than just the blood.
Additionally, appropriate compensation for both acute and chronic disorders can be determined and corrected for when interpreting the blood gas results. The results are presented in a couple of different ways: as graphs with 90%
confidence intervals, or as a set of calculation rules. This book uses the rules method because these can be easily committed to memory and can be easily used at the bedside when assessing patients with acid-base disorders. Within the traditional approach to acid-base analysis, the Boston 'bicarbonate method' is preferable to the Copenhagen 'base excess method' because:
• it is simpler to understand and to teach
• it is based on whole body experiments rather than on test tube results on a blood sample
• it emphasises the need for clinical assessment and interpretation rather than being driven by laboratory based derived quantities
Quote from the original critique of Schwartz and Relman in 1963
"The traditional measurements of pH, pCO 2 and plasma bicarbonate concentration continue to be the most reliable biochemical guides in the analysis of acid-base disturbances. These measurements, when 
